Andrea Sambati
Chief Executive Officer at Boehringer Ingelheim (Canada) Ltd.
Andrea Sambati active positions
| Companies | Position | Start | End |
|---|---|---|---|
Boehringer Ingelheim (Canada) Ltd.
 Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Chief Executive Officer | - | - |
| President | - | - | |
Boehringer Ingelheim Animal Health Canada, Inc.
 Boehringer Ingelheim Animal Health Canada, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada. | Director/Board Member | 2019-07-31 | - |
| Chief Executive Officer | 2019-07-31 | - |
Career history of Andrea Sambati
Statistics
International
| Canada | 3 |
Operational
| Chief Executive Officer | 2 |
| President | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Health Technology |
Boehringer Ingelheim Animal Health Canada, Inc.
Boehringer Ingelheim Animal Health Canada, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada. | Health Technology |
- Stock Market
- Insiders
- Andrea Sambati
- Experience
